Patents by Inventor Masahiko Morita

Masahiko Morita has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210088045
    Abstract: Provided is a liquid supply mechanism including: a plurality of liquid supply sections each including a plurality of branch paths whose central axes intersect with each other, and a supply path having a side surface to which the plurality of branch paths of the plurality of liquid supply sections are directly connected, respectively, and supplying liquid, which is supplied from an upstream, to the branch paths.
    Type: Application
    Filed: December 4, 2018
    Publication date: March 25, 2021
    Inventors: Kotaro CHIBA, Masahiko TAKANO, Shigeyuki YORIKANE, Kenji MORITA, Yoshitaka TAKEUCHI
  • Patent number: 10905705
    Abstract: An objection of the present invention is to provide an agent for preventing or improving decline in brain function such as decreased perception ability, decreased memory learning ability, decreased thinking ability, decreased concentration, decreased attention, decreased judgment ability, depression, and decreased exercise performance caused thereby. According to the present invention, an agent for protecting brain neuronal cells, comprising citrulline or a salt thereof and citicoline or a salt thereof as active ingredients as well as an agent for preventing or improving decline in brain function, comprising citrulline or a salt thereof and citicoline or a salt thereof as active ingredients is provided.
    Type: Grant
    Filed: October 30, 2013
    Date of Patent: February 2, 2021
    Assignee: KYOWA HAKKO BIO CO., LTD.
    Inventors: Kota Kumagai, Masahiko Morita, Takahiro Hara, Kohji Fukunaga
  • Publication number: 20210017988
    Abstract: A technique is provided that can further reduce power at the time of “unload operation control” in a gas compressor that generates a compressed gas at a set pressure by constant-speed control. The gas compressor includes a compressor main unit, a drive source, an intake throttle valve, a gas release valve, rotation speed converting means, a pressure detecting device that detects a discharge pressure, and a controller that, the relationship between an upper-limit pressure H and a lower-limit pressure L being H>L, carries out opening the intake throttle valve and closing the gas release valve and operating the drive source at a full-load rotation speed until the discharge pressure reaches the upper-limit pressure H. The controller carries out at least one of closing the intake throttle valve and opening the gas release valve to reduce the discharge pressure to within a predetermined range when the discharge pressure reaches the upper-limit pressure H.
    Type: Application
    Filed: March 26, 2019
    Publication date: January 21, 2021
    Inventors: Masakazu HASE, Hideharu TANAKA, Akira IYOZUMI, Masahiko TAKANO, Kenji MORITA, Shigeyuki YORIKANE, Takashi NAKAJIMA, Yoshihiko SAGAWA
  • Publication number: 20200386229
    Abstract: A screw compressor includes a screw rotor, a casing, and a fluid supply portion to supply fluid in a membrane form into a compression chamber in the casing. The screw rotor has a male and female rotors. A male bore covering the male rotor and a female bore covering the female rotor are formed on the inner surface of the casing. An intersection line, on a higher pressure side, of the male and female bores is defined as a compression cusp. In a bore development view, a trajectory made by the first intersection of an extension line of a female lobe ridge and a male lobe ridge being moved, along with the rotation of the male and female rotors, is defined as a trajectory line. An opening of the fluid supply section to the compression chamber is positioned between the compression cusp and the trajectory line.
    Type: Application
    Filed: August 6, 2018
    Publication date: December 10, 2020
    Inventors: Kotaro CHIBA, Masahiko TAKANO, Shigeyuki YORIKANE, Kenji MORITA, Yoshitaka TAKEUCHI, Minako KANADA
  • Publication number: 20200378385
    Abstract: A screw compressor includes: a screw rotor including a rotor section and a shaft section; a casing having a shaft hole through which the shaft section is inserted, the casing housing the screw rotor; and a delivery side shaft sealing unit configured to seal a clearance between the shaft section and the shaft hole against leakage of a working fluid. The delivery side shaft sealing unit includes an annular groove provided in the shaft section, a seal ring disposed movably in an axial direction of the shaft section within the annular groove, the seal ring being capable of sliding contact with the shaft hole and a side wall surface of the annular groove, and a shaft sealing fluid supply passage communicating with the shaft hole and supplying a fluid to one side, in an axial direction, of the seal ring.
    Type: Application
    Filed: February 21, 2018
    Publication date: December 3, 2020
    Inventors: Kotaro CHIBA, Masahiko TAKANO, Kenji MORITA, Yoshitaka TAKEUCHI, Takeshi TSUCHIYA
  • Patent number: 10823848
    Abstract: A detection apparatus that includes correlation processing systems that each find a correlation between a predetermined code sequence and a wave detection signal obtained by detecting a phase-modulated input wave at a frequency different from a frequency used by a different one of the correlation processing systems, and thereby generate a correlation signal, level reduction processors that each receive the correlation signal from a corresponding one of the plurality of correlation processing systems and reduce a level of the received correlation signal when the correlation signal is not to be used for detection of the target or do not reduce the level of the received correlation signal when the correlation signal is to be used for detection of the target, and a detector that detects at least presence or absence of the target based on the correlation signal processed by each of the plurality of level reduction processors.
    Type: Grant
    Filed: February 27, 2018
    Date of Patent: November 3, 2020
    Assignee: Panasonic Intellectual Property Management Co., Ltd.
    Inventors: Tadashi Morita, Masahiko Hashimoto
  • Patent number: 10627258
    Abstract: In a related-art resolver, a front and a back of a stator core cannot be distinguished, and it is difficult to mass-produce the resolver while matching directions of shear drops and burrs. Thus, assembly accuracy of the resolver is degraded. Further, productivity and assembling ability are degraded because electromagnetic steel sheets are laminated by rotary lamination. The present invention provides a resolver including: a resolver stator including: a stator core formed of electromagnetic steel sheets, which have teeth, and are laminated without rotary lamination; a one-phase excitation winding; and two-phase output windings; and a resolver rotor arranged to be opposed to the resolver stator, in which the stator core has marks which enable distinction of a rolling direction of the stator core and distinction of a front and a back of the stator core.
    Type: Grant
    Filed: August 21, 2014
    Date of Patent: April 21, 2020
    Assignee: Mitsubishi Electric Corporation
    Inventors: Yusuke Morita, Atsushi Yamamoto, Masahiko Fujita, Naohiro Motoishi, Kazumasa Ito, Masatsugu Nakano
  • Publication number: 20200108034
    Abstract: The invention provides citrulline or a salt thereof and glutathione or a salt thereof for use in increasing a ratio of muscle mass to total body weight in a person in conjunction with a resistance workout program, as well as a method of increasing a ratio of muscle mass to total body weight in a person by administering citrulline or a salt thereof and glutathione or a salt thereof to the person in conjunction with a resistance workout program. The citrulline and glutathione or salts thereof are administered daily for a period greater than 7 days, whereas the resistance workout program is administered for at least the entire period during which the two compounds are administered. The muscle mass is measured by a body composition meter.
    Type: Application
    Filed: May 31, 2018
    Publication date: April 9, 2020
    Applicant: KYOWA HAKKO BIO CO., LTD.
    Inventors: Masahiko MORITA, Ayako KAMIMURA, Darryn S. WILLOUGHBY
  • Publication number: 20200102950
    Abstract: A liquid-feed-type gas compressor that can monitor the liquid surface height in a gas-liquid separator is provided.
    Type: Application
    Filed: March 27, 2018
    Publication date: April 2, 2020
    Inventors: Kenji MORITA, Masahiko TAKANO, Shigeyuki YORIKANE
  • Patent number: 10369186
    Abstract: An objection of the present invention is to provide an agent for preventing or improving decline in brain function such as decreased perception ability, decreased memory learning ability, decreased thinking ability, decreased concentration, decreased attention, decreased judgment ability, depression, and decreased exercise performance caused thereby. According to the present invention, an agent for protecting brain neuronal cells, comprising citrulline or a salt thereof and glutathione or a salt thereof as active ingredients as well as an agent for preventing or improving decline in brain function, comprising citrulline or a salt thereof and glutathione or a salt thereof as active ingredients is provided.
    Type: Grant
    Filed: October 30, 2013
    Date of Patent: August 6, 2019
    Assignee: KYOWA HAKKO BIO CO., LTD.
    Inventors: Kota Kumagai, Masahiko Morita, Takahiro Hara, Kohji Fukunaga
  • Patent number: 10288732
    Abstract: A detection device includes: a first correlation circuit that computes correlation of a first wave detection signal, which is a phase-modulated input wave detected at determined frequency, with a determined code sequence for every code composing the determined code sequence, and to generate first correlation signals the number of which corresponds to a code sequence length, which is a length of the determined code sequence; and a control circuit that rotates phases of the first correlation signals, generates an added value by adding the phase-rotated first correlation signals, and determines based on the added value whether the phase-modulated input wave is a return wave from a determined object.
    Type: Grant
    Filed: September 18, 2017
    Date of Patent: May 14, 2019
    Assignee: PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD.
    Inventors: Tadashi Morita, Masahiko Hashimoto
  • Patent number: 9833426
    Abstract: An agent for enhancing NO production, comprising citrulline or a salt thereof and serine or a salt thereof as an active ingredient. An agent for preventing or ameliorating vascular endothelial malfunction, comprising citrulline or a salt thereof and serine or a salt thereof as an active ingredient. An agent for preventing or ameliorating a symptom caused by vascular endothelial malfunction, comprising citrulline or a salt thereof and serine or a salt thereof as an active ingredient.
    Type: Grant
    Filed: June 28, 2013
    Date of Patent: December 5, 2017
    Assignee: Kyowa Hakko Bio Co., Ltd.
    Inventors: Masahiko Morita, Miho Yin Komatsu, Takahiro Hara
  • Publication number: 20170049796
    Abstract: A method of improving both motor function and cognitive function of healthy human subjects through administration of citicoline or its salt in high dosage or low dosage for a period of time, resulting in improved motor function and cognitive function.
    Type: Application
    Filed: April 30, 2015
    Publication date: February 23, 2017
    Applicant: KYOWA HAKKO BIO CO., LTD.
    Inventors: Deborah Yurgelun-Todd, Perry Renshaw, Miho Takada, Takeshi Ikeda, Masahiko Morita
  • Publication number: 20170042962
    Abstract: An agent for preventing or ameliorating vascular endothelial malfunction and arteriosclerosis-related symptoms caused by the progress of vascular endothelial malfunction (e.g., ischemic diseases such as myocardial infarction, angina, and peripheral artery occlusion) or low blood flow-related symptoms (e.g., stiff shoulders, excessive sensitivity to cold, swelling, erectile dysfunction, rough skin and decrease in exercise performance due to skeletal muscle hypoactivity), which has an improved NO production enhancing effect is provided. A NO production enhancer comprising citrulline or a salt thereof and glutathione or a salt thereof as active ingredients. An agent for preventing or ameliorating vascular endothelial malfunction, comprising citrulline or a salt thereof and glutathione or a salt thereof as active ingredients. An agent for preventing or ameliorating a symptom caused by vascular endothelial malfunction, comprising citrulline or a salt thereof and glutathione or a salt thereof as active ingredients.
    Type: Application
    Filed: October 26, 2016
    Publication date: February 16, 2017
    Inventors: Masahiko Morita, Miho Komatsu, Takahiro Hara
  • Patent number: 9480668
    Abstract: The present invention provides a blood flow promoting agent containing citrulline or a salt thereof and capsaicin or capsaicinoids as active ingredients, which is safe even by long-term administration, a food with health claims and a functional food affording such action, particularly, a blood flow promoting agent exhibiting an effective vasodilatory action of capsaicin at a low dose free of irritant property, which can be applied to improvement of athletic performance exhibited in relation to peripheral vasodilatation, suppression of fat accumulation, improvement of skin quality, as well as securing blood circulation in ischemic disease and the like, relaxation of blood vessel biased to coarctation due to advancing age, lifestyle-related diseases and the like, prophylaxis of arteriosclerosis, and prophylaxis of stiff neck, feeling of cold, erectile dysfunction, thrombosis and the like due to blood flow disorder.
    Type: Grant
    Filed: November 5, 2013
    Date of Patent: November 1, 2016
    Assignee: Kyowa Hakko Bio Co., Ltd.
    Inventors: Masahiko Morita, Ayako Kamimura, Yoshinori Kobayashi
  • Publication number: 20160296586
    Abstract: An agent for preventing or ameliorating vascular endothelial malfunction and arteriosclerosis-related symptoms caused by the progress of vascular endothelial malfunction (e.g., ischemic diseases such as myocardial infarction, angina, and peripheral artery occlusion) or low blood flow-related symptoms (e.g., stiff shoulders, excessive sensitivity to cold, swelling, erectile dysfunction, rough skin and decrease in exercise performance due to skeletal muscle hypoactivity), which has an improved NO production enhancing effect is provided. A NO production enhancer comprising citrulline or a salt thereof and glutathione or a salt thereof as active ingredients. An agent for preventing or ameliorating vascular endothelial malfunction, comprising citrulline or a salt thereof and glutathione or a salt thereof as active ingredients. An agent for preventing or ameliorating a symptom caused by vascular endothelial malfunction, comprising citrulline or a salt thereof and glutathione or a salt thereof as active ingredients.
    Type: Application
    Filed: June 21, 2016
    Publication date: October 13, 2016
    Inventors: Masahiko Morita, Miho Komatsu, Takahiro Hara
  • Patent number: 9420223
    Abstract: An image recording device capable of obtaining a moving image with less noise even in a low illuminance environment when obtaining a moving image having a wide dynamic range. An image pickup device picks up an image of an object over different exposure time periods to output a plurality of image signals. The plurality of image signals output from the image pickup device are synthesized to thereby obtain a synthesized image. The synthesized image is recorded in a memory at a predetermined frame rate. Respective vertical transfer periods for reading out the plurality of image signals are differentiated according to the different exposure time periods, and the sum of the vertical transfer periods is controlled to a time period defined by the predetermined frame rate.
    Type: Grant
    Filed: September 20, 2012
    Date of Patent: August 16, 2016
    Assignee: CANON KABUSHIKI KAISHA
    Inventor: Masahiko Morita
  • Patent number: 9392954
    Abstract: A classification estimating system can include an input element group; an intermediate element group into which are input values of first intermediate variables for which a first multiple desensitization, including an accumulation of values of each input element of a first input element group and each value of a first output sensitivity and each value of a first multiplex output sensitivity, has been carried out and calculated; an output element group into which is input a value of an output variable calculated based on a value of each intermediate element of a first intermediate element group and a value of each connection weight; a classification information estimating module for estimating classification information based on pre-stored correspondence relationship information and a value of the output variable; and a classification information display.
    Type: Grant
    Filed: January 13, 2012
    Date of Patent: July 19, 2016
    Assignee: University of Tsukuba
    Inventors: Masahiko Morita, Hiroshi Kawata
  • Publication number: 20150352067
    Abstract: An agent for elevating nitric oxide (NO) concentration comprising glutathione or a salt thereof as an active ingredient; an agent for elevating NO concentration comprising glutathione or a salt thereof as an active ingredient for preventing or ameliorating a vascular endothelial malfunction-related symptom, or dilating blood vessels or promoting blood flow by elevating NO concentration; and a method for elevating NO concentration by ingesting glutathione or a salt thereof.
    Type: Application
    Filed: January 21, 2014
    Publication date: December 10, 2015
    Inventors: Masahiko MORITA, Ayako KAMIMURA
  • Publication number: 20150306125
    Abstract: An objection of the present invention is to provide an agent for preventing or improving decline in brain function such as decreased perception ability, decreased memory learning ability, decreased thinking ability, decreased concentration, decreased attention, decreased judgment ability, depression, and decreased exercise performance caused thereby. According to the present invention, an agent for protecting brain neuronal cells, comprising citrulline or a salt thereof and citicoline or a salt thereof as active ingredients as well as an agent for preventing or improving decline in brain function, comprising citrulline or a salt thereof and citicoline or a salt thereof as active ingredients is provided.
    Type: Application
    Filed: October 30, 2013
    Publication date: October 29, 2015
    Inventors: Kota Kumagai, Masahiko Morita, Takahiro Hara, Kohji Fukunaga